Metronidazole vs. Macrobid
See how Metronidazole and Macrobid compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Metronidazole treats anaerobic bacterial and protozoal infections like bacterial vaginosis and trichomoniasis, while Macrobid is used specifically for uncomplicated urinary tract infections.
Both drugs can cause nausea and headache, but metronidazole carries a boxed warning for carcinogenicity and a severe reaction with alcohol that Macrobid does not share.
Macrobid concentrates in urine and works poorly outside the urinary tract, while metronidazole reaches therapeutic levels throughout the body.
Metronidazole vs. Macrobid Drug Summary
Metronidazole
Metronidazole is a nitroimidazole antibiotic used to treat anaerobic bacterial infections, trichomoniasis, bacterial vaginosis, and amebiasis. It is taken orally, usually two to three times a day for 7 to 10 days depending on the infection, and also comes as an IV, topical, or vaginal formulation.
Macrobid
Macrobid (nitrofurantoin) is a urinary anti-infective used only for uncomplicated bladder infections caused by susceptible E. coli or S. saprophyticus. It is taken orally as one 100 mg capsule every 12 hours for 7 days and works almost entirely within the urinary tract.
Metronidazole vs. Macrobid Side Effects
Metronidazole
Macrobid
Metronidazole vs. Macrobid Dosage
Metronidazole
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg three times daily | Days 1-7 |
| Maximum dose | 500-750 mg three times daily | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Metronidazole
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg three times daily | Days 1-7 |
| Maximum dose | 500-750 mg three times daily | If needed |
| Dose changes | 2 increases | As tolerated |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Metronidazole vs. Macrobid Indications
Metronidazole
Metronidazole is FDA-approved for a range of anaerobic and protozoal infections, including trichomoniasis, bacterial vaginosis, amebiasis, and intra-abdominal infections. Doctors also prescribe it off-label, often combined with other antibiotics, to treat Clostridioides difficile and Helicobacter pylori infections.
Trichomoniasis (symptomatic and asymptomatic)
Bacterial vaginosis
Amebiasis
Intra-abdominal infections (peritonitis, abscess)
Macrobid
Macrobid is FDA-approved only for acute, uncomplicated urinary tract infections caused by E. coli or S. saprophyticus. It is sometimes used off-label at a lower dose for long-term prevention of recurrent UTIs, but it is not approved for kidney infections or infections outside the bladder.
Acute uncomplicated UTI (cystitis)
Recurrent UTI prevention (off-label, low dose)
Not approved for pyelonephritis
Not approved for children under 12
Metronidazole vs. Macrobid Pros and Cons
Metronidazole
Metronidazole is inexpensive, covers a broad range of anaerobic bacteria and parasites, and comes in oral, IV, topical, and vaginal forms. It carries a boxed warning for carcinogenicity in animal studies and causes a severe reaction if combined with alcohol.
Pros
Broader spectrum: covers anaerobic bacteria and parasites
Available in oral, IV, topical, and vaginal forms
Roughly $15 to $40 per month, before insurance
Cons
Boxed warning for carcinogenicity in animal studies
Causes disulfiram-like reaction with alcohol
Metallic taste is a common complaint
Risk of seizures and peripheral neuropathy
Macrobid
Macrobid works almost entirely in the urinary tract, which limits its usefulness for infections elsewhere but keeps its side effect profile mostly local. It is contraindicated in significant kidney impairment and carries warnings for rare but serious lung and liver reactions with long-term use.
Pros
Minimal systemic absorption limits body-wide side effects
Still reliably effective against E. coli
First-line option for uncomplicated cystitis
Cons
Contraindicated with creatinine clearance under 60 mL/min
Risk of pulmonary fibrosis with long-term use
Roughly $80 to $200 per month, before insurance
Not effective for pyelonephritis or systemic infections
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.